Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
01 1Cohance Lifesciences
02 4Alfred E Tiefenbacher GmbH
03 2ANGITA PHARMA INC.
04 3Actavis Inc
05 2Adcock Ingram
06 5Alembic Pharmaceuticals Limited
07 4Alphapharm PTY Ltd
08 2Anchen Pharmaceutical, Inc
09 8Apotex Inc
10 4Arrow Pharmaceuticals
11 2Ascent Innovative Medicines
12 2Aspire Lifesciences Pvt Ltd
13 2Cipla Medpro South Africa
14 2Eurofarma Laboratorios S.A
15 4Generic Health
16 3Hikma Pharmaceuticals
17 2INNOVATA PHARMACEUTICALS
18 2Intellipharmaceutics Corporation
19 2JAMP PHARMA
20 1Jivita Health Care
21 3Lupin Ltd
22 2NORVIUM BIOSCIENCE
23 1Noucor
24 2Osmotica Pharmaceuticals
25 2PRO DOC LIMITEE
26 4Pfizer Consumer Healthcare
27 7Pfizer Inc
28 2Pharma Dynamics
29 2Precise Group
30 3Rubicon Research
31 2SANIS HEALTH INC
32 10Sandoz B2B
33 2Taro Pharmaceutical Industries
34 2Teva Pharmaceutical Industries
35 4WAGNER PHARMACEUTICALS PTY LTD
36 5Yichang Humanwell Pharmaceutical
37 3Zydus Pharmaceuticals
38 6Blank
01 4Coated Tablet
02 3ER Tablet
03 2Extended Release Tablet
04 4Extended-Release Tablet
05 2FCT
06 2Granules
07 4Prolonged Release tablet
08 1Sustain Release Pellet
09 1Sustained Release Tablet
10 8TAB
11 20TABLET (EXTENDED-RELEASE)
12 34TABLET, EXTENDED RELEASE;ORAL
13 2Tablet
14 32Blank
01 4DISCN
02 4EU Dossier Readiness-Q1 2020
03 10Generic
04 2Originator
05 28RX
06 71Blank
01 128 Enzude 100Mg Extended Release Tablets
02 128 Enzude 50Mg Extended Release Tablets
03 2AG-DESVENLAFAXINE
04 2APO-DESVENLAFAXINE
05 2APO-DESVENLAFAXINE EXTENDED-RELEASE TABLETS
06 4APO-Desvenlafaxine MR
07 4BTC Desvenlafaxine
08 4DESVEN
09 8DESVENLAFAXINE
10 25DESVENLAFAXINE SUCCINATE
11 4DESVENLAFAXINE-WGR XR
12 1Depven 100 XL
13 1Depven 50 XL
14 4Desfax
15 2Deslafeks
16 1Deslafore XR 100
17 1Deslafore XR 50
18 4Desvenlafaxine GH XR
19 4Desvenlafaxine Sandoz
20 1Exlov XR 100 mg
21 1Exlov XR 50 mg
22 1Exsira 100mg
23 1Exsira 50mg
24 2JAMP DESVENLAFAXINE
25 2KHEDEZLA
26 5PRISTIQ
27 4Pristiq
28 1Pristiq 100Mg Extended Release Tablets 28
29 1Pristiq 50Mg Extended Release Tablets 28
30 2SANDOZ DESVENLAFAXINE
31 2TARO-DESVENLAFAXINE
32 2TEVA-DESVENLAFAXINE
33 19Blank
01 32Australia
02 4Brazil
03 20Canada
04 2China
05 4Germany
06 8India
07 10South Africa
08 5Spain
09 34USA
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Sustain Release Pellet
Dosage Strength : 41.38%
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
We are the TIEFENBACHER GROUP, Health Pioneers since 1963.
Regulatory Info : EU Dossier Readiness-Q1 2020
Registration Country : Germany
Brand Name :
Dosage Form : Prolonged Release tablet
Dosage Strength : 50MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : EU Dossier Readiness-Q1 2020
Registration Country : Germany
We are the TIEFENBACHER GROUP, Health Pioneers since 1963.
Regulatory Info : EU Dossier Readiness-Q1 2020
Registration Country : Germany
Brand Name :
Dosage Form : Prolonged Release tablet
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : EU Dossier Readiness-Q1 2020
Registration Country : Germany
We are the TIEFENBACHER GROUP, Health Pioneers since 1963.
Regulatory Info : EU Dossier Readiness-Q1 2020
Registration Country : Germany
Brand Name :
Dosage Form : Prolonged Release tablet
Dosage Strength : 50MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : EU Dossier Readiness-Q1 2020
Registration Country : Germany
We are the TIEFENBACHER GROUP, Health Pioneers since 1963.
Regulatory Info : EU Dossier Readiness-Q1 2020
Registration Country : Germany
Brand Name :
Dosage Form : Prolonged Release tablet
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : EU Dossier Readiness-Q1 2020
Registration Country : Germany
Regulatory Info : RX
Registration Country : USA
Brand Name : DESVENLAFAXINE SUCCINATE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : EQ 25MG BASE
Packaging :
Approval Date : 2016-07-29
Application Number : 204065
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DESVENLAFAXINE SUCCINATE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : EQ 50MG BASE
Packaging :
Approval Date : 2016-07-29
Application Number : 204065
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DESVENLAFAXINE SUCCINATE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : EQ 100MG BASE
Packaging :
Approval Date : 2016-07-29
Application Number : 204065
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DESVENLAFAXINE SUCCINATE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : EQ 50MG BASE
Packaging :
Approval Date : 2015-06-29
Application Number : 204003
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DESVENLAFAXINE SUCCINATE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : EQ 100MG BASE
Packaging :
Approval Date : 2015-06-29
Application Number : 204003
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DESVENLAFAXINE SUCCINATE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : EQ 25MG BASE
Packaging :
Approval Date : 2018-09-14
Application Number : 204003
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DESVENLAFAXINE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 50MG
Packaging :
Approval Date : 2013-03-04
Application Number : 204150
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DESVENLAFAXINE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 100MG
Packaging :
Approval Date : 2013-03-04
Application Number : 204150
Regulatory Info : RX
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : DESVENLAFAXINE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 50MG
Packaging :
Approval Date :
Application Number : 204009
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : DESVENLAFAXINE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number : 204009
Regulatory Info :
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DESVENLAFAXINE SUCCINATE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : EQ 50MG BASE
Packaging :
Approval Date : 2016-02-16
Application Number : 204082
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DESVENLAFAXINE SUCCINATE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : EQ 25MG BASE
Packaging :
Approval Date : 2017-08-28
Application Number : 204082
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DESVENLAFAXINE SUCCINATE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : EQ 100MG BASE
Packaging :
Approval Date : 2016-02-16
Application Number : 204083
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DESVENLAFAXINE SUCCINATE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : EQ 50MG BASE
Packaging :
Approval Date : 2015-06-29
Application Number : 204172
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : PRISTIQ
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : EQ 50MG BASE
Packaging :
Approval Date : 2008-02-29
Application Number : 21992
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : PRISTIQ
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : EQ 100MG BASE
Packaging :
Approval Date : 2008-02-29
Application Number : 21992
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : PRISTIQ
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : EQ 25MG BASE
Packaging :
Approval Date : 2014-08-20
Application Number : 21992
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DESVENLAFAXINE SUCCINATE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : EQ 50MG BASE
Packaging :
Approval Date : 2015-06-29
Application Number : 204028
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DESVENLAFAXINE SUCCINATE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : EQ 100MG BASE
Packaging :
Approval Date : 2015-06-29
Application Number : 204028
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DESVENLAFAXINE SUCCINATE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : EQ 25MG BASE
Packaging :
Approval Date : 2023-12-07
Application Number : 204028
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DESVENLAFAXINE SUCCINATE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : EQ 50MG BASE
Packaging :
Approval Date : 2017-10-11
Application Number : 204020
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DESVENLAFAXINE SUCCINATE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : EQ 100MG BASE
Packaging :
Approval Date : 2017-10-11
Application Number : 204020
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DESVENLAFAXINE SUCCINATE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : EQ 25MG BASE
Packaging :
Approval Date : 2022-11-30
Application Number : 204020
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : DESVENLAFAXINE SUCCINATE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : EQ 50MG BASE
Packaging :
Approval Date : 2015-06-29
Application Number : 204095
Regulatory Info : DISCN
Registration Country : USA
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info : DISCN
Registration Country : USA
Brand Name : DESVENLAFAXINE SUCCINATE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : EQ 100MG BASE
Packaging :
Approval Date : 2015-06-29
Application Number : 204095
Regulatory Info : DISCN
Registration Country : USA
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
LOOKING FOR A SUPPLIER?
